CDR2 抗体 (C-Term)
Quick Overview for CDR2 抗体 (C-Term) (ABIN363590)
抗原
See all CDR2 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- C-Term
- 
                                            特异性
- Reacts with ~51 kDa CDR2 protein from human, mouse, bovine, primate
- 
                                            交叉反应
- 大鼠
- 
                                            交叉反应 (详细)
- May cross react with rat (85 % sequence homology).
- 
                                            纯化方法
- Antigen affinity purified
- 
                                            免疫原
- Synthetic peptide made to a C-terminal region of the human protein
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- 
                        Working dilution: Optimal dilution should be determined by the end user. 
 The following are guidelines only :
 - IHC : 5 to 10 μg/mL - WB : 2 μg/mL
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- 1 mg/mL
- 
                                            缓冲液
- Tris-citrate, phosphate, ( pH 7-8) buffer, Sodium azide 0.1 %
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C/-80 °C
- 
                                            储存方法
- Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
 
- 
                                            
- 
    - CDR2 (Cerebellar Degeneration-Related Protein 2, 62kDa (CDR2))
- 
                                            别名
- Cerebellar Degeneration-Related Protein 2
 抗原
- 
                    
 
                                     
                                     
                                    